Insider Transactions in Q4 2020 at Procter & Gamble CO (PG)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 27
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
51,867
-33.51%
|
$7,365,114
$142.94 P/Share
|
Oct 27
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
51,867
+25.03%
|
$3,941,892
$76.66 P/Share
|
Oct 23
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
35,054
-11.42%
|
$4,977,668
$142.67 P/Share
|
Oct 23
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
35,054
+10.25%
|
$2,909,482
$83.87 P/Share
|
Oct 22
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
71,391
-49.05%
|
$10,066,131
$141.42 P/Share
|
Oct 22
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
95,170
+39.53%
|
$7,232,920
$76.18 P/Share
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
79,380
-35.27%
|
$11,351,340
$143.75 P/Share
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Exercise of conversion of derivative security
|
Direct |
79,380
+26.04%
|
$6,747,300
$85.5 P/Share
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
19,863
-39.74%
|
$2,860,272
$144.0 P/Share
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Exercise of conversion of derivative security
|
Indirect |
19,863
+28.41%
|
$1,688,355
$85.5 P/Share
|
Oct 13
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+6.21%
|
-
|
Oct 13
2020
|
Debra L Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+50.0%
|
-
|
Oct 13
2020
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+15.8%
|
-
|
Oct 13
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+6.81%
|
-
|
Oct 13
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+2.97%
|
-
|
Oct 13
2020
|
Margaret C Whitman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+5.47%
|
-
|
Oct 13
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+4.65%
|
-
|
Oct 13
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+26.68%
|
-
|
Oct 13
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+1.63%
|
-
|
Oct 13
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+3.72%
|
-
|
Oct 13
2020
|
Peltz Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+20.66%
|
-
|
Oct 01
2020
|
Valarie L Sheppard Controller, Treas. & Group VP |
BUY
Grant, award, or other acquisition
|
Direct |
2,694
+9.36%
|
-
|
Oct 01
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,599
+4.89%
|
-
|
Oct 01
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Grant, award, or other acquisition
|
Direct |
2,969
+5.51%
|
-
|
Oct 01
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Indirect |
674
+6.32%
|
-
|
Oct 01
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Grant, award, or other acquisition
|
Direct |
3,051
+5.94%
|
-
|
Oct 01
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,326
+9.02%
|
-
|
Oct 01
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Grant, award, or other acquisition
|
Direct |
12,024
+8.57%
|
-
|
Oct 01
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Grant, award, or other acquisition
|
Direct |
5,136
+9.25%
|
-
|
Oct 01
2020
|
David S Taylor Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,910
+6.18%
|
-
|